Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management

被引：16

作者：

Ahmed, Kamran A. ^{[1
]}

Kim, Sungjune ^{[1
]}

Harrison, Louis B. ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2017年 / 26卷 / 03期

关键词：

Abscopal effect; Bystander effect; Immune checkpoint inhibitors; Radiation therapy; IMMUNOGENIC CELL-DEATH; BRAIN METASTASES; STEREOTACTIC RADIOSURGERY; IPILIMUMAB IMMUNOTHERAPY; CLINICAL-OUTCOMES; TUMOR-CELLS; OPEN-LABEL; CANCER; NIVOLUMAB; RADIOTHERAPY;

D O I：

10.1016/j.soc.2017.01.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunotherapy has revolutionized the systemic management of numerous malignancies. Nowhere has the proven benefit of these agents in clinical practice been more evident than in the management of advanced melanoma. Numerous preclinical studies have revealed the potential benefit of immune-priming radiotherapy in stimulating tumor-specific immune responses. This signal for immune activation may lead to clinically relevant synergy with immune checkpoint inhibitors against malignant cells. In this review, the authors summarize the current data outlining the role radiation therapy may play in the management of advanced melanoma alongside immune checkpoint inhibitors.

引用

页码：515 / +

页数：16

共 50 条

[41] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges [J].

Liu, Xiufeng ;

Qin, Shukui .

ONCOLOGIST, 2019, 24 :S3-S10

[42] Safety of immune checkpoint inhibitors in Chinese patients with melanoma [J].

Wen, Xizhi ;

Wang, Yao ;

Ding, Ya ;

Li, Dandan ;

Li, Jingjing ;

Guo, Yiqun ;

Peng, Ruiqing ;

Zhao, Jingjing ;

Zhang, Xing ;

Zhang, Xiao-Shi .

MELANOMA RESEARCH, 2016, 26 (03) :284-289

[43] Progress in Immune Checkpoint Inhibitor for Melanoma Therapy [J].

Boutros, Celine ;

Herrscher, Hugo ;

Robert, Caroline .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (05) :997-1010

[44] The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges [J].

Guven, Deniz Can ;

Sahin, Taha Koray ;

Rizzo, Alessandro ;

Ricci, Angela Dalia ;

Aksoy, Sercan ;

Sahin, Kazim .

APPLIED SCIENCES-BASEL, 2022, 12 (20)

[45] Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case series [J].

Uematsu, Mao ;

Nakajima, Hiromichi ;

Hosono, Ako ;

Kiyohara, Hikari ;

Hirota, Akira ;

Takahashi, Nobuyuki ;

Fukuda, Misao ;

Kusuhara, Shota ;

Nakao, Takehiro ;

Funasaka, Chikako ;

Kondoh, Chihiro ;

Harano, Kenichi ;

Matsubara, Nobuaki ;

Naito, Yoichi ;

Akimoto, Tetsuo ;

Mukohara, Toru .

MELANOMA RESEARCH, 2023, 33 (06) :547-552

[46] Response rate and local recurrence after concurrent immune checkpoint therapy and radiotherapy for non-small cell lung cancer and melanoma brain metastases [J].

Qian, Jack M. ;

Martin, Allison M. ;

Martin, Kate ;

Hammoudeh, Lubna ;

Catalano, Paul J. ;

Hodi, F. Stephen ;

Cagney, Daniel N. ;

Haas-Kogan, Daphne A. ;

Schoenfeld, Jonathan D. ;

Aizer, Ayal A. .

CANCER, 2020, 126 (24) :5274-5282

[47] Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety [J].

Azoury, Said C. ;

Straughan, David M. ;

Shukla, Vivek .

CURRENT CANCER DRUG TARGETS, 2015, 15 (06) :452-462

[48] The progress of combination therapy with immune checkpoint inhibitors in breast cancer [J].

Fan, Kaimin ;

Weng, Junwei .

BIOCELL, 2023, 47 (06) :1199-1211

[49] Immune checkpoint inhibitors in metastatic colorectal cancer therapy (a review) [J].

Sorochan, P. P. ;

Hromakova, I. A. ;

Prokhach, N. E. ;

Hromakova, I. S. .

ZAPOROZHYE MEDICAL JOURNAL, 2020, 24 (03) :354-364

[50] Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors [J].

Jeung, Hei-Cheul ;

Oh, Se Eung ;

Kim, Jee Hung .

JOURNAL OF RHEUMATIC DISEASES, 2019, 26 (04) :221-234

← 1 2 3 4 5 →